                               SEQUENCE LISTING

<110> REALTA LIFE SCIENCES, INC.
 
<120> PEPTIDES AND METHODS OF USE

<130> 251110.000139

<140> PCT/US2021/052174
<141> 2021-09-27

<150> 63/185,831
<151> 2021-05-07

<150> 63/085,556
<151> 2020-09-30

<160> 3     

<170> PatentIn version 3.5

<210> 1
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Ile Ala Leu Ile Leu Glu Pro Ile Cys Cys Gln Glu Arg Ala Ala 
1               5                   10                  15  


<210> 2
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> C-terminal monodisperse 24-mer PEGylated moiety

<400> 2
Ile Ala Leu Ile Leu Glu Pro Ile Cys Cys Gln Glu Arg Ala Ala 
1               5                   10                  15  


<210> 3
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Sarcosine

<400> 3

Ile Ala Leu Ile Leu Glu Pro Xaa Cys Cys Gln Glu Arg Ala Ala 
1               5                   10                  15  
